Warning! GuruFocus detected
1 Severe warning sign
with DRMA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Dermata Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US2498453065
Description
Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.44 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 73.4 | |||||
| 3-Year EPS without NRI Growth Rate | 76 | |||||
| 3-Year FCF Growth Rate | 71.5 | |||||
| 3-Year Book Growth Rate | -87.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 87.05 | |||||
| 9-Day RSI | 76.18 | |||||
| 14-Day RSI | 67.87 | |||||
| 3-1 Month Momentum % | -12.69 | |||||
| 6-1 Month Momentum % | -25.56 | |||||
| 12-1 Month Momentum % | -80.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.79 | |||||
| Quick Ratio | 1.79 | |||||
| Cash Ratio | 1.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -315.9 | |||||
| Shareholder Yield % | -89.24 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -310.54 | |||||
| ROA % | -214.68 | |||||
| ROIC % | -2738.29 | |||||
| 3-Year ROIIC % | 13694.12 | |||||
| ROCE % | -316.27 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.29 | |||||
| Price-to-Tangible-Book | 2.29 | |||||
| EV-to-EBIT | -0.33 | |||||
| EV-to-EBITDA | -0.33 | |||||
| EV-to-FCF | -0.37 | |||||
| Price-to-Net-Current-Asset-Value | 2.29 | |||||
| Price-to-Net-Cash | 3.02 | |||||
| Earnings Yield (Greenblatt) % | -303.03 | |||||
| FCF Yield % | -144.69 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:DRMA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dermata Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -14.521 | ||
| Beta | 0.75 | ||
| 3-Year Sharpe Ratio | -2.13 | ||
| 3-Year Sortino Ratio | -1.97 | ||
| Volatility % | 51.55 | ||
| 14-Day RSI | 67.87 | ||
| 14-Day ATR ($) | 0.159791 | ||
| 20-Day SMA ($) | 1.22046 | ||
| 12-1 Month Momentum % | -80.31 | ||
| 52-Week Range ($) | 1 - 6.665999 | ||
| Shares Outstanding (Mil) | 5.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dermata Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dermata Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dermata Therapeutics Inc Frequently Asked Questions
What is Dermata Therapeutics Inc(DRMA)'s stock price today?
The current price of DRMA is $1.42. The 52 week high of DRMA is $6.67 and 52 week low is $1.00.
When is next earnings date of Dermata Therapeutics Inc(DRMA)?
The next earnings date of Dermata Therapeutics Inc(DRMA) is .
Does Dermata Therapeutics Inc(DRMA) pay dividends? If so, how much?
Dermata Therapeutics Inc(DRMA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers